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Abstract
The idea of this chapter is that currently available antidiabetic drugs specifically 
target several points of the T2D pathophysiology but they do not cover all aspects of the 
disease. In addition, many adverse effects of synthetic antidiabetic agents have been 
reported. The suggested manuscript is an overview of the available scientific literature 
focused on antiobesity and antidiabetic potential of selected 42 medicinal and edible 
plants of the Bulgarian flora. Most of the reports reveal the effect of extracts or their 
active components on specific biochemical mechanisms. Mechanistic data about hypo-
glycemic and hypolipidemic action are presented for some of the plants. An essential 
part of this review is dedicated to the target mechanisms behind the effects of the 
selected plant species. The authors hope that this review will serve as a starting point 
for future investigations with a contribution to the prevention and therapy of diabetes.
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1. Introduction
Diabetes is an endocrine disease related to impaired glucose metabolism due to 
either impaired insulin secretion or decreased sensitivity to its function, classified, 
respectively, as type 1 diabetes (T1D) and type 2 diabetes (T2D). Over time, chronic 
hyperglycemia can cause secondary micro- and macrovascular complications affecting 
the functions of the eyes, kidneys, peripheral nerves, and arteries. According to recent 
alarming data, the number of adults living with diabetes has almost quadrupled since 
1980 to 2014. This dramatic rise is largely due to the number of T2D sufferers [1].
Although some of the characteristics of the modern lifestyle (obesity, stress, low 
physical activity) are considered to be risk factors with regard to the occurrence of 
diabetes, it should be noted that cases of the disease are described in written sources dat-
ing back to 3500 years [2–4]. Also, records exist from ancient Egypt, India, and Persia, 
indicating a long history of medicinal use of plants for treatment of conditions associ-
ated with diabetes [5]. Historical and archeological sources indicate that Thracians, the 
most ancient tribes on the territory of Bulgaria, were familiar with the healing power of 
the plants [6]. Over the years, empirical data about healing properties of plants used in 
Bulgarian folk medicine and traditional nutrition have been collected in several reference 
books [7–10]. Although plants have been used to treat diabetes for centuries, the number 
of species with completely clarified antidiabetic mechanisms of action is still limited.
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No. Plant Common name Used parts References
1 Achillea millefolium L. 
(Asteraceae)
White yarrow Aerial parts [13–20]
2 Agrimonia eupatoria L. 
(Rosaceae)
Agrimony Aerial parts [21–31]
3 Alchemilla vulgaris L. 
(Rosaceae)
Lady’s Mantle Stalk [21, 32, 33]
4 Arctium lappa L. (Asteraceae) Burdock Root [21, 34–36]
5 Arctostaphylos uva-ursi L. 
(Ericaceae)
Bearberry Leaves [37, 38]
6 Asparagus officinalis L. 
(Liliaceae)
Sparrow grass Stalk [39–41]
7 Berberis vulgaris L. 
(Berberidaceae)
Barberry Fruits [42–44]
8 Betula sp. (Betulaceae) Birch Leaves [45, 46]
9 Cichorium intybus L. 
(Asteraceae)
Blue daisy, blue 
dandelion
Stalk, root [13, 14, 21, 
47]
10 Cotinus coggygria Scop. 
(Anacardiaceae)
Smoke tree, sumach Leaves [25, 48]
11 Cydonia vulgaris Pers. 
(Rosaceae)
Quince Leaves [49–51]
12 Foeniculum vulgare Mill. 
(Apiaceae)
Dill Fruits [52–54]
13 Fragaria vesca complex 
(Rosaceae)
Wild strawberry Leaves [33, 55, 56]
14 Galega officinalis L. 
(Fabaceae)
Goat’s rue Stalk [21, 57–59]
15 Hypericum perforatum L. 
(Hypericaceae)
St. John’s wort Stalk [25, 60, 61]
16 Juglans regia L. (Juglandaceae) Walnut Leaves [62–69]
17 Juniperus communis L. 
(Cupressaceae)
Juniper Fruits [13, 14, 21, 
31]
18 Lavandula angustifolia Mill. 
(Liliaceae)
Lavender Flower [21, 25, 70, 
71]
19 Melissa officinalis L. 
(Liliaceae)
Melissa, lemon balm Stalk [25, 58, 71, 
72]
20 Mentha piperita L. (Liliaceae) Mint Leaves [33, 71]
21 Morus nigra L. (Moraceae) Мulberry Leaves, fruits, root 
bark, heartwood
[13, 14], 
76–82
22 Ocimum basilicum L. 
(Liliaceae)
Basil Leaves [73–75]
23 Ononis spinosa L. (Lamiaceae) Spiny restharrow Root [62]
24 Origanum vulgare L. 
(Liliaceae)
Marjoram Stalk [25, 83–85]
25 Pelargonium sp. (Geraniaceae) Pelargonium Leaves [86, 87]
26 Phaseolus vulgaris L. 
(Fabaceae)
Bean Pods [13, 14, 21, 
88–91]
27 Plantago major L. 
(Plantaginaceae)
Broadleaf plantain Leaves [62]
28 Polygonum aviculare L. 
(Polygonaceae)
Prostrate knotweed, 
birdweed, pigweed
Stalk [26]
29 Rheum officinale Baill. 
(Polygonaceae)
Rhubarb Root [92, 93]
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Currently available antidiabetic drugs could specifically target several points of the 
T2D pathophysiology, but they do not cover all aspects of the disease [11, 12]. In addi-
tion, many adverse effects of synthetic antidiabetic agents have been reported [11].
Therefore, it is not surprising that in recent years, the scientific interest is 
focused on identifying naturally derived compounds and preparations with hope to 
address more aspects of the disease without undesirable side effects.
This chapter is an overview of the available scientific literature focused on 
antiobesity and antidiabetic potential of selected 42 medicinal and edible plants of 
the Bulgarian flora. Most of the reports reveal the effect of extracts or their active 
components on specific biochemical mechanisms. Mechanistic data for hypogly-
cemic and hypolipidemic action are presented for some of the plants (references 
summarized in Table 1). An essential part of this review is dedicated to the target 
mechanisms behind the effects of the selected plant species.
Without claiming exhaustiveness, the authors hope that this review will serve as 
a starting point for future investigations with a contribution to the prevention and 
therapy of diabetes.
2.  Effects of plants and plant-derived compounds on glucose homeostasis
2.1 Inhibition of digestive enzymes and glucose absorption in the intestine
Carbohydrates are an essential part of the human diet and are the main energy 
source of the body. Starch, sucrose, lactose, and glycogen are the main utilizable 
No. Plant Common name Used parts References
30 Rosa canina L. (Rosaceae) Rose hip Fruits [55, 94–96]
31 Rosa damascenа auct. non-Mill. 
(Rosaceae)
Oil rose Flower [97–98]
32 Rubus sp. diversae Бlackberry Leaves [21, 25, 100, 
101]
33 Salvia officinalis L. (Liliaceae) Garden sage Leaves [19, 47, 
102–106]
34 Sambucus ebulus L. 
(Caprifoliaceae)
Dwarf elderberry Fruits [33, 107–110]
35 Sambucus nigra L. 
(Caprifoliaceae)
European black 
elderberry
Flower [34, 111–113]
36 Taraxacum officinale Wigg. 
(Asteraceae)
Dandelion Root stalk [19, 21, 34, 
81, 114]
37 Thymus sp. diversae 
(Liliaceae)
Thyme Stalk [19, 77]
38 Tilia platyphyllos Scop. 
(Tiliaceae)
Lime tree Flower [37, 115]
39 Urtica dioica L. (Urticaceae) Nettle Stalk [34, 67, 
116–120]
40 Vaccinium myrtillus L. 
(Ericaceae)
Blueberry Leaves and fruits [13, 14, 21, 
81]
41 Veronica officinalis L. 
(Scrophulariaceae)
Veronica, speedwell, 
Paul’s betony
Stalk [121, 122]
42 Zea mays L. (Poaceae) Corn Silk [21, 123]
Table 1. 
References in support of potentially antidiabetic properties of 42 selected plants.
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carbohydrates in human diet. After the action of salivary and pancreatic α-amylase, 
the digestion products of starch and glycogen along with disaccharides are further 
digested in the small intestine epithelium, where the membrane-bound enzyme 
α-glucosidase, as well as various disaccharidases (saccharase, maltase, lactase), cata-
lyze the release of glucose, fructose, and galactose. Monosaccharides are absorbed 
through the walls of the small intestine and reach the liver by the portal vein.
Inhibition of digestive enzymes is one possible approach to control early-stage 
hyperglycemia. Inhibition of α-amylase and α-glucosidase can significantly delay 
the increase in glucose concentration in the postprandial phase [124–127].
For a significant part of the plants presented in Table 1, data on the inhibitory 
effect of their extracts or active components on digestive enzymes in different 
experimental approaches were reported (Table 2). In vitro studies have found 
that aqueous extracts of basil and walnut leaves exert an inhibitory effect on 
α-amylase and α-glucosidase as well as on some disaccharidases without affecting 
insulin secretion and glucose transport proteins [63, 79]. Both studies suggest that 
polyphenols play a major role in the observed effects, as an extremely rich content 
of these active compounds in the two extracts is found. Another study [128] dem-
onstrated a strong inhibitory activity of walnuts on the activity of α-amylase and 
disaccharidases.
Except aqueous extract of thyme, the extracted essential oil of the plant also 
exhibits an inhibitory effect on the amylase and glucosidase; Paddy et al. [19] and 
Pongpiriyadacha et al. [46] found that birch extract significantly reduced blood 
glucose levels after oral administration of sucrose to rats, a result demonstrating 
the inhibitory action of the extract on α-glucosidase. The same extract in an in vitro 
study had a concentration-dependent inhibitory effect on α-glucosidase, saccha-
rase, and maltase.
2.2 Effects on glucose homeostasis in the liver
The liver has an essential role in maintenance of glucose homeostasis by control-
ling the utilization of excess glucose after meal for glycogen synthesis or secretion 
of free glucose into the circulation through glycogenolysis and gluconeogenesis 
(GNG) in fasting periods. Insulin and glucagon have a major regulatory role in the 
activity of these processes. In the periods when the nutrients do not enter the body, 
all the glucose coming into the circulation is delivered by the liver [129]. Upon food 
intake, increased glucose levels stimulate secretion of insulin, which has an inhibi-
tory effect on hepatic mechanisms delivering free glucose.
In diabetic patients, this regulation is impaired, and even an increased activity of 
the key enzymes of gluconeogenesis and glycogenolysis is detected [130, 131].
Galega officinalis has been used from ancient times to alleviate polyuria in diabetic 
patients. Its active ingredients guanidine and gelagine have been shown to inhibit the 
enzyme fructose-1,6-bisphosphatase and glucose-6-phosphatase (Table 2).
Fructose-1,6-bisphosphatase is a rate-limiting enzyme in GNG, and its activity 
has been reported to be pathologically elevated in experimental models of insulin 
resistance (IR) and obesity [132]. Therefore, inhibition of the enzyme could be 
a promising target to overcome the chronic hyperglycemia and to maintain nor-
moglycemic status during fasting periods. The search for new GNG inhibitors of 
natural origin may be of great importance in the control of diabetes, especially for 
patients intolerant to synthetic therapeutics [11].
Glucose-6-phosphatase is a key enzyme in GNG and glycogenolysis, catalyzing 
the last step—release of free glucose from the liver.
Several plants from our list are described to exert their hypoglycemic action by 
inhibiting enzymes from GNG (Table 2). According to folk medicine, Melissa sp. has 
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Metabolic pathway/
mechanism
Effects on 
molecular targets
Plant 
No.
Type of studies
Carbohydrate digestion 
and absorption
↓ α-amylase 1, 3, 6, 
8, 22, 
26, 30, 
31, 33, 
36, 37, 
39
Spectrophotometrical assessment 
of enzyme inhibition; STZ-induced 
diabetes; kinetics of enzyme inhibition
↓ α-glucosidase 1, 6, 8, 
22, 26, 
30, 31, 
33, 36, 
37
Spectrophotometrical assessment of 
enzyme inhibition; glucose oxidase-
based method
↓ Disaccharidases 16, 22 Intestinal sucrase and maltase in rats 
with alloxan-induced diabetes
↓ Glucose 
absorption
1, 17, 
33, 36, 
37
Intestinal cell cultures; diabetic rodents
GNG PEPCK 16, 19, 
21
Gene expression in hepatocytes of 
diabetic rodents
Fructose-1,6-
bisphosphatase
14 Experimental and clinical studies with 
metformin
Glucose-6 
phosphatase
14, 19 Gene expression in hepatocytes of 
diabetic rodents; experimental and 
clinical studies with metformin
Glycogen synthesis Glucokinase 16, 19 Gene expression in hepatocytes of 
diabetic rodents
Glycogen synthase 2, 6, 35 STZ-induced diabetes in rats; mice 
muscle cell cultures
Polyol pathway Aldose reductase 5, 24, 
42
Diabetic rodents; in vitro enzyme 
activity in rats lences
Glucose uptake in IDTs GLUT-4 
translocation
1, 16, 
18, 19, 
20,, 26, 
33, 36, 
37, 41
Glucose uptake in C2C12 myotubes; gene 
expression in 3T3-L1 cell culture
Insulin secretion SUR1 and Ca2+ 
channels
1, 2, 4, 
6, 9, 16, 
28
[Ca2+] and [insulin] in pancreatic beta cells
Lipid metabolism ↓ TAG 1, 2, 13, 
16, 26, 
30, 34
Rats with alloxan- or STZ-induced 
diabetes; human intervention studies 
3T3-L1 cell cultures
↓ VLDL 1 Rats with alloxan- or STZ-induced 
diabetes
↓ HMG-CoA 
reductase
4, 9, 
20, 22, 
31, 39
Macrophage and 3T3-L1 cell cultures
↓ Total cholesterol 1, 2, 16, 
33, 34
Rats with alloxan- or STZ-induced 
diabetes; human intervention studies
↓ LDL 1, 2, 34 Rats with alloxan- or STZ-induced 
diabetes; human intervention studies
↑ HDL 16, 34, 
36
Rats with alloxan- or STZ-induced 
diabetes; human intervention studies; 
cholesterol fed rabbits
↑ HDL/LDL ratio 2, 34 Human intervention studies
Plant numbers are in the order as they are listed in Table 1.
Table 2. 
Mechanisms of action of selected plants in respect of their antidiabetic potential; ↑-activation, ↓-inhibition.
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pronounced spasmolytic and antibacterial action and a slight anxiolytic effect [7]. 
Scientific data from recent years reveal the antidiabetic potential of the plant ([72]. It 
was demonstrated that chronic administration of neral and geranial essential oils to db/
db mice had significant hypoglycemic effect, due to their stimulatory and, respectively, 
inhibitory effects on the gene expression of glucokinase and glucose-6-phosphatase.
The enzyme glucokinase, also called the “glucose sensor,” has a key role in the pan-
creas and liver to maintain glucose homeostasis. Due to the fact that the enzyme has a 
high Km value for glucose, its role is to provide an excess of glucose (by phosphoryla-
tion to glucose-6-phosphate) to activate insulin secretion and glycogen synthesis. 
The search for active compounds that can stimulate the enzyme is a relatively new 
concept in the pharmacological approaches to diabetes treatment [11], and probably 
the role of medicinal plants as sources of such activators is yet to be explored.
The key enzyme for glycogen synthesis is glycogen synthase. Agrimonia 
eupatoria L., Asparagus officinalis L., and Sambucus nigra L. have shown a stimu-
lating effect on the enzyme activity, but the mechanisms behind this effect remain 
unclear. Treatment with agrimony and sparrow grass extracts has resulted in 
increased amount of glycogen in the muscles and liver of rats with streptozotocin-
induced diabetes [23, 39]. Elderberry aqueous extract applied to isolated mouse 
muscle cells stimulated both glucose transport and oxidation as well as glycogen 
synthesis [111]. Similarly, in cells and animal studies, it was found that prepara-
tions and active compounds from Morus sp. have inhibitory effects on gene 
expression of all regulatory GNG enzymes, including phosphoenolpyruvate 
carboxykinase (PEPCK) [133, 134].
2.3 Inhibition of polyol pathway of glucose metabolism
The most serious problems resulting from diabetes mellitus are the complica-
tions due to increased blood glucose levels.
The body has several options to metabolize the excess glucose. Among them, the 
polyol pathway is of utmost importance for the development of diabetic complica-
tions. Catalyzed by the aldose reductase enzyme, glucose is converted to sorbitol, an 
osmotically active metabolite which accumulates and damages the cells [135]. It has 
been shown that inhibition of aldose reductase is preventive against the develop-
ment of micro- and macrovascular diabetic complications [136, 137].
For three of the selected medicinal plants, data exist about their inhibitory effect 
on aldose reductase (Table 2). Treatment of diabetic mice with ursolic acid isolated 
from the bearberry resulted in a reduction in fructose and sorbitol levels in the kid-
neys [38]. Active components of oregano (caffeic and rosmarinic acid) and of maize 
hair (hirsutrin) have proven in their in vitro inhibitory action on aldose reductase 
activity in rat lenses [83, 123].
Research on potential enzyme inhibitors has so far not led to the development 
of therapeutics of general usage [138]. Although scarce, data on such activity of 
medicinal plants is promising in future quests for such a therapeutic approach.
2.4 Effects of glucose transport in insulin-dependent tissues
Insulin modulates several metabolic pathways by activating the phosphati-
dylinositol-3-kinase (PI3K) cascade, including intracellular translocation of the 
GLUT-4 transport protein for glucose in skeletal and adipose tissues. In diabetes, 
the transfer of GLUT-4 towards plasma membrane cannot be accomplished.
The hypoglycemic properties of some medicinal plants are due to the ability 
of their active components to promote the translocation of GLUT-4 to the plasma 
membrane, resulting in a decrease in blood glucose concentration [20, 90, 106, 139].
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Hypoglycemic potential based on this mechanism has been reported primarily 
for essential oils of lavender, lemon balm, and mint [71, 72]. Luteolin, the flavan 
derived from Veronica officinalis, was shown to activate both the expression and 
translocation of the glucose transport protein [140].
2.5 Hypoglycemic activity of plants: putative mechanisms
Much of the data with regards to the antidiabetic activity of the plants were 
obtained using models of pharmacologically induced diabetes in experimental ani-
mals. The most commonly used diabetes-inducing agents are streptozotocin (STZ) 
and alloxan [141]. Both compounds have destructive effects on pancreatic β cells by 
different mechanisms. STZ enters the β cells through the transport protein GLUT-2 
and damages DNA, resulting in overexpression of DNA repair systems and thus 
leading to depletion of cell stores of ATP and oxidized nicotinamide dinucleotide 
(NAD+) [142, 143]; alloxan, transported by GLUT-2, depletes the thiol groups in the 
cells, establishing a permanent redox cycle with the dialuric acid (its reduced form). 
This process leads to the accumulation of ROS and hence to the destruction of β 
cells, which in general have very limited store of endogenous antioxidants [144].
The models of in vivo induced diabetes are informative in terms of the hypo-
glycemic and insulin-like effects of plant extracts. For example, such was the effect 
of the aqueous oregano extract applied over a period of several weeks to rats with 
STZ-induced diabetes. In this study, the established potential of the extract to lower 
blood sugar and glycated hemoglobin was comparable to that of the antidiabetic 
drug glibenclamide [84]. In another similar in vivo study, the plant extract exhib-
ited an insulin-like effect normalizing blood glucose levels without affecting plasma 
basal insulin levels [145]. Similar data was also obtained about black mulberry leaf 
extract [74]. However, in addition to the hypoglycemic effect, an increase in the 
insulin levels was reported, which may be attributed to the protective and possibly 
stimulatory action of the plant on β cells’ function. Data on the antidiabetic proper-
ties of Phaseolus vulgaris exist in folk medicine of different ethnic groups [146]. 
At present, many scientific studies confirm the hypoglycemic and hypolipidemic 
potential of the plant (predominantly of the pod extract), both in experimentally 
induced diabetes and in human intervention studies [147–149]. Vaccinium myrtil-
lus fruits had beneficial effect on obese subjects in a 6-week intervention study as 
measured by improved insulin sensitivity, inflammatory biomarker levels, and lipid 
profile [150]. Zea mays hair extracts, as recommended by folk medicine as an anti-
diabetic remedy, was shown to reduce blood sugar and glycated hemoglobin levels, 
to stimulate β cells’ function and increase serum insulin levels in an experimental 
model of diabetes [151, 152]. Hypoglycemic and insulin-like effects have also been 
reported for Taraxacum officinale roots, for fruits and flowers of Sambucus nigra, 
stalks of Alchemilla vulgaris and Achillea millefolium, roots from Arctium lappa and 
Urtica dioica, Cydonia vulgaris leaves, and other plants presented in Table 1.
3. Effects of plants on insulin secretion
There are two mechanisms by which medicinal plants or their active components 
possibly stimulate insulin secretion [153]:
• Plant active compounds bind to sulfonylurea binding site 1 (SUR1) of К+-АТP 
channels resulting in channel closure and membrane depolarization.
• Direct activation of Са2+ channels.
Nutrition in Health and Disease - Our Challenges Now and Forthcoming Time
8
Sulfonylurea derivatives, such as glibenclamide, are applied for treatment of 
T2D to stimulate translocation of insulin-containing secretory granules to plasma 
membrane and exocytosis of insulin in the extracellular matrix [11].
Medicinal plants with an effect on insulin secretion are presented in Table 2.
It should be noted that according to most of the studies, the stimulatory activity 
of medicinal plants on insulin secretion is attributed to their antioxidative potential 
and ability to prevent SZT- and alloxan-induced beta cell injury in experimental 
models of diabetes.
4. Plants that affect lipid metabolism
Defined as abnormal accumulation of adipose tissue, obesity is a major health 
problem worldwide [154]. As a condition that accompanies obesity, dyslipidemia 
is believed to be a basic factor for the development of obesity-related diseases such 
as T2D, cardiovascular diseases (CVD), and atherosclerosis [155]. Dyslipidemia is 
characterized by increased triacylglycerol (TAG) and total cholesterol levels and 
unfavorable changes in HDL-/LDL-cholesterol ratio [156, 157].
Many plants that are considered to have antidiabetic potential have beneficial 
effects on the lipid profile in addition to their hypoglycemic activities [158, 159]. 
These properties are attributed to their naturally occurring secondary metabolites, 
such as bioflavonoides.
Anthocyanin extracts and anthocyanin-rich diet can improve the parameters of 
lipid profile and therefore are considered to have anti-obesity and anti-atherogenic 
effects in humans and in rodents [160–164].
Sambucus ebulus (dwarf elderberry) is a plant widely used in Bulgarian folk 
medicine in various pathological conditions. Its fruits are rich in anthocyanins. 
Studies report that anthocyanin extracts can reduce body mass and adipose tissue 
volume in rats fed with high-fat and high-fructose diet [160, 165–167]. There are 
reports describing the also hypoglycemic activity of the S. ebulus fruits in rats on 
high-fat and high-fructose diet [168, 169].
A 30-day human intervention study with S. ebulus fruit tea decreased signifi-
cantly TAG, total cholesterol, and LDL-cholesterol levels. Slight increase of HDL 
and significant increase in HDL/LDL ratio were found ([110].
Low HDL levels are recognized as an independent risk factor for the develop-
ment of cardiovascular diseases [170]. Inhibition of cholesteryl ester transfer protein 
(CETP) is a probable cause for the increased HDL-cholesterol levels, and LDL-
cholesterol levels decrease upon anthocyanin treatment [171]. Anthocyanins can 
decrease quantity and the activity of CETP in plasma of dyslipidemic patients [161].
The scientific data cited above are in support to the folk medicine reports about 
the healing properties of S. ebulus fruit preparations.
Likewise, lipid profile improving properties have been reported for Agrimonia 
eupatoria (agrimony). Its effect on lipid profile was estimated in our study in a 
model of metabolic disturbances in rats on high-fructose diet. Intake of 40% 
aqueous-ethanol extract prevented fat accumulation in the liver and adipose tissue 
and normalized levels of serum lipids [167].
In addition, we performed a human intervention study with 30-day agrimony 
tea consumption. As a result, increased levels of HDL cholesterol were established, 
and LDL-cholesterol levels remained unchanged at the same time [29]. These 
results reveal good potential of agrimony to improve lipid profile, which is impor-
tant in prophylaxis of CVD and diabetes.
It can be assumed that polyphenols play a role in the mechanisms by which the 
plant manifests its effects. It is known that diet rich in polyphenols may improve 
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lipid profile in individuals with normal or compromised health status [172, 173]. 
Polyphenol preparations and polyphenol-rich extracts have also the potential to 
improve lipid profile [174–177]. As it was already mentioned, S. ebulus fruits are a 
rich source of polyphenols and especially of anthocyanins [33, 108]. Also, it was 
found that the aqueous and aqueous alcoholic extracts of agrimony have a high 
polyphenol content [25, 178], although their exact polyphenol composition has not 
yet been identified. Polyphenols have limited bioavailability; however, many of the 
products of their intestinal metabolism overcome the intestinal barrier and reach 
the tissues where they exert their biological effects [179].
Some of the selected plants (Table 1) can exert their effects by inhibiting the 
activity of the rate-limiting enzyme in cholesterol synthesis—HMG-CoA reductase 
[99]. Cholesterol is the most abundant sterol in the human body and is essential for 
the normal functioning of the cells. Cholesterol homeostasis is of great importance 
for the health status. Apart from being a risk factor for atherosclerosis, increased 
plasma cholesterol levels are often an accompanying parameter of the metabolic 
disturbances, such as diabetes. Despite being applied for decades, HMG-CoA 
reductase inhibitors have adverse and unwanted effects, such as myopathy, liver 
insufficiency, etc. [99].
Even more, in a case of strictly controlled LDL-cholesterol levels by statins, not 
always TAG and HDL-cholesterol levels are sensitive to the therapy, and there is 
still a chance that CVD risk would remain high [180]. Interventions with S. ebulus 
and A. eupatoria tea resulted in significantly increased HDL/LDL ratio; beneficial 
effects of these plants on plasma TAG and total cholesterol levels were established, 
so it is likely that the plants improve all parameters of the lipid profile. This makes 
them promising sources of active compounds with a potential to prevent and 
supplement the therapy of T2D and CVD.
In addition to the above, scientific data about the beneficial effects of rosehip, 
strawberries, and raspberries on lipid metabolism and inflammation exist (Table 1). 
These plants are rich in the glycoside flavonoid tiliroside, which was shown to inhibit 
postprandial inflammation, to play a role in the prevention of obesity, hyperinsu-
linemia, and hyperlipidemia. Its action is associated with elevated levels of adipo-
nectin and also facilitated fatty acids oxidation in the liver and skeletal muscles [181]. 
Strawberry anthocyanin pelargonidin sulfate and pelargonidin-3-O-glycoside reduced 
postprandial inflammation and increased insulin sensitivity in overweight individuals 
[56]. Polyphenols extracted from strawberry decreased postprandial LDL oxidation 
and enhanced lipid metabolism in a high-fat intervention with overweight individuals 
with hyperlipidemia [182]. Six of the plants listed in Table 1 (Arctium lappa, Cichorium 
intybus, Mentha piperita, Ocimum basilicum, Rosa damascenа, Urtica dioica) had also 
inhibitory effect of HMG-CoA reductase. Among them, the extract of R. damascena 
was found to be the most potent one [99].
The discovery of new effective and safe in long-term application therapeutics is 
essential for the control and prevention of obesity-related diseases. In this respect, 
the potential of medicinal and edible plants is still to be explored.
5. Conclusions
The summarized scientific data give а concept about the mechanisms behind 
the healing effects of plants traditionally used in Bulgarian folk medicine and 
traditional diet. The selected plants and their active compounds could exert their 
hypoglycemic and antiobese effects by affecting simultaneously several molecular 
markers in various processes from carbohydrate and lipid metabolism. Moreover, 
along with their insulin-like properties, many of the plants can stimulate the insulin 
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by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
secretion. This makes them invaluable in prevention and therapy of socially signifi-
cant diseases such as diabetes and cardiovascular diseases. Despite the capacity of 
biotechnology methods to develop new therapeutics, it may be worth to turn a look 
at the natural resources which potential is still unrevealed.
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